Effect of protein kinase C and insulin on Na+/H+ exchange in red blood cells of essential hypertensives

Journal of Human Hypertension

Volumn 13, Issue 5, 1999, Pages 321-327

  Ceolotto, G ^a   Sartori, M ^a   Felice, M ^a   Clari, G ^a   Bordin, L ^a   Semplicini, Andrea ^a,b  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Erythrocytes; Essential hypertension; Phorbol ester; Protein kinase C; Sodium proton exchange; Transport kinetics

Indexed keywords

CARRIER PROTEIN; CELL ENZYME; CELL MEMBRANE PROTEIN; INSULIN; PROTEIN KINASE C;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ERYTHROCYTE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; MALE; PROTEIN PROCESSING; PROTON SODIUM EXCHANGE; PROTON TRANSPORT;

EID: 0033058376     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000804     Document Type: Article

References (30)

1. Mahnensmith RL, Aronson PS. The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological processes. Circ Res 1985; 56: 773-778.
2. Frohlich O, Karmazyn M. The Na-H exchanger revisited: an update on Na-H exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease. Cardiovasc Res 1997; 36: 138-148.
3. Canessa M et al. Kinetic abnormalities of the red blood cell sodium-proton exchange in hypertensive patients. Hypertension 1991; 17: 340-348.
4. Canessa M, Falkner B, Hulmann S. Red blood cell sodium-proton exchange in hypertensive blacks with insulin-resistant glucose disposal. Hypertension 1993; 22: 204-213.
5. + exchange in vascular smooth muscle cells from WKY and SHR: effects of phorbol ester. Am J Physiol 1993; 268: C14-C20.
6. Rosskopf D, Fromter E, Siffert W. Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients. J Clin Invest 1993; 92: 2553-2559.
7. + antiporter as a candidate gene in human essential hypertension. Hypertension 1991; 17: 8-14.
8. + antiporter phenotype, abundance, and phosphorylation of immortalized lymphoblasts from humans with hypertension. Hypertension 1995; 25: 971-977.
9. + exchanger, NHE-1, by phosphorylating a set of common sites. J Biol Chem 1991; 266: 19166-19171.
10. + exchanger kinase. Circulation Res 1997; 81: 268-273.
11. Nishizuka Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein Kinase C. Science 1992; 258: 607-614.
12. + exchangers. Physiol Rev 1997; 77: 51-74.
13. + exchange. Am J Physiol 1997; 272 Cell Physiol, 41): C818-C826.
14. + exchange. Nutr Metab Cardiovasc Dis 1997; 7: 57-62.
15. + exchange decreases the affinity of sodium sites. Kidney Int 1994; 46: 365-375.
16. Schmitz-Pfeiffer C et al. Alteration in the expression and cellular localization of protein kinase C isozymes epsilon and theta associated with insulin resistance in skeletal muscle of high-fat-fed rat. Diabetes 1997; 46: 169-178.
17. + exchange in hypertensive patients. J Hypertens 1995; 13: 1566-1570.
18. + exchangers. Meth Enzymol 1989; 173: 176-191.
19. + exchanger. J Membr Biol 1989; 107: 219-228.
20. 2+-dependent phosphorylation of human red cell membrane skeletal proteins. J Biol Chem 1986; 261: 7701-7709.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J Biol Chem 1951; 193: 265-275.
22. + countertransport activity in essential hypertensive patients. Eur J Clin Invest 1996; 26: 64-70.
23. + exchanger in rabbit renal brush border membranes. J Clin Invest 1993; 91: 2097-2102.
24. + exchanger isoforms. Am J Physiol 1995; 268: C283-C296.
25. Bossenmaier B et al. Protein kinase C isoforms beta 1 and beta 2 inhibit the tyrosyne kinase activity of the insulin receptor. Diabetologia 1997; 40: 863-866.
26. Dwyer LD et al. Calpain-induced downregulation of activated protein kinase Ca affects lung epithelial cell morphology. Am J Physiol 1994; 267: L569-L576.
27. Pontremoli S et al. Erythrocyte deficiency in calpain inhibitor activity in essential hypertension. Hypertension 1988; 12: 474-478.
28. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Eng J Med 1996; 334: 374-381.
29. Kellerer M et al. Protein kinase C isoforms α, δ, and θ require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (HEK 293 cells). Diabetologia 1998; 41: 833-838.
30. 2+. Diabetes 1998; 47: 352-357.